Impact of HIV subtype on response and resistance in antiretroviral-naïve adults comparing treatment with once daily versus twice daily ritonavir boosted fosamprenavir in combination with Abacavir/Lamivudine. Drugs Ther Studies [Internet]. 2011 Dec. 30 [cited 2025 Jul. 1];2(1):e1. Available from: https://journals.pagepress.org/dts/article/view/dts.2012.e1